{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T06:15:08Z","timestamp":1772259308565,"version":"3.50.1"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":274,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Dermatol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1111\/ced.12504","type":"journal-article","created":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T09:49:32Z","timestamp":1417427372000},"page":"136-141","source":"Crossref","is-referenced-by-count":20,"title":["Clinical remission of psoriatic arthritis in patients receiving continuous biological therapies for 1\u00a0year: the experience of an outpatient dermatological clinic for psoriasis"],"prefix":"10.1093","volume":"40","author":[{"given":"D.","family":"Graceffa","sequence":"first","affiliation":[{"name":"Centre for the Study and Treatment of Psoriasis at the Department of Clinical Dermatology; San Gallicano Dermatologic Institute; IRCCS; 00144 Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Maiani","sequence":"additional","affiliation":[{"name":"Centre for the Study and Treatment of Psoriasis at the Department of Clinical Dermatology; San Gallicano Dermatologic Institute; IRCCS; 00144 Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Sperduti","sequence":"additional","affiliation":[{"name":"Biostatistic Division; Scientific Direction; San Gallicano Dermatologic Institute; IRCCS; 00144 Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ceralli","sequence":"additional","affiliation":[{"name":"Department of Rheumatology; San Camillo-Forlanini Hospital; Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bonifati","sequence":"additional","affiliation":[{"name":"Centre for the Study and Treatment of Psoriasis at the Department of Clinical Dermatology; San Gallicano Dermatologic Institute; IRCCS; 00144 Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,12,1]]},"reference":[{"key":"10.1111\/ced.12504-BIB0001|ced12504-cit-0001","first-page":"279","article-title":"Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis","volume":"15","author":"Gisondi","year":"2005","journal-title":"Eur J Dermatol"},{"key":"10.1111\/ced.12504-BIB0002|ced12504-cit-0002","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/176298","article-title":"Psoriatic arthritis: an update","volume":"2012","author":"Lloyd","year":"2012","journal-title":"Arthritis"},{"key":"10.1111\/ced.12504-BIB0003|ced12504-cit-0003","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0140-6736(13)60594-2","article-title":"Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo controlled PSUMMIT 1 trial","volume":"382","author":"McInners","year":"2013","journal-title":"Lancet"},{"key":"10.1111\/ced.12504-BIB0004|ced12504-cit-0004","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11926-008-0048-z","article-title":"Remission in psoriatic arthritis","volume":"10","author":"Vlam","year":"2008","journal-title":"Curr Rheumatol Rep"},{"issue":"Suppl.","key":"10.1111\/ced.12504-BIB0005|ced12504-cit-0005","first-page":"78","article-title":"Criteria, frequency, and duration of clinical remission in psoriatic arthritis patients with peripheral involvement requiring second-line drugs","volume":"36","author":"Cantini","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1111\/ced.12504-BIB0006|ced12504-cit-0006","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/ar3021","article-title":"Remission in psoriatic arthritis: is it possible and how can it be predicted ?","volume":"12","author":"Saber","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1111\/ced.12504-BIB0007|ced12504-cit-0007","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/kei153","article-title":"Efficacy, effectiveness and safety of etanercept in monotherapy for refractory psoriatic arthritis: a 26-week observational study","volume":"45","author":"Vlam","year":"2006","journal-title":"Rheumatology"},{"key":"10.1111\/ced.12504-BIB0008|ced12504-cit-0008","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10067-009-1340-7","article-title":"Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs","volume":"29","author":"Atteno","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1111\/ced.12504-BIB0009|ced12504-cit-0009","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1759720X10389847","article-title":"Is remission a more realistic goal in psoriatic arthritis?","volume":"3","author":"Saber","year":"2011","journal-title":"Ther Adv Musculoskel Dis"},{"key":"10.1111\/ced.12504-BIB0010|ced12504-cit-0010","unstructured":"WHO Obesity and overweight http:\/\/www.who.int\/mediacentre\/factsheets\/fs311\/en\/"},{"key":"10.1111\/ced.12504-BIB0011|ced12504-cit-0011","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1468-3083.2011.04138.x","article-title":"The diagnosis of early psoriatic arthritis in an outpatient dermatological centre for psoriasis","volume":"26","author":"Bonifati","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/ced.12504-BIB0012|ced12504-cit-0012","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1111\/ced.12504-BIB0013|ced12504-cit-0013","first-page":"62","article-title":"Reliability of measurements of active and damaged joints in psoriatic arthritis","volume":"17","author":"Gladman","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1111\/ced.12504-BIB0014|ced12504-cit-0014","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000250839","article-title":"Severe psoriasis - oral therapy with a new retinoid","volume":"157","author":"Fredriksson","year":"1978","journal-title":"Dermatologica"},{"key":"10.1111\/ced.12504-BIB0015|ced12504-cit-0015","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/art.23568","article-title":"Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis","volume":"59","author":"Healy","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1111\/ced.12504-BIB0016|ced12504-cit-0016","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1780230202","article-title":"Measurement of patient outcome in arthritis","volume":"23","author":"Fries","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1111\/ced.12504-BIB0017|ced12504-cit-0017","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/ced.12504-BIB0018|ced12504-cit-0018","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter\u00a0criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1111\/ced.12504-BIB0019|ced12504-cit-0019","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/rheumatology\/keq091","article-title":"Time and predictors of response to tumour necrosis factor-a blockers in psoriatic arthritis: an analysis of a longitudinal observational cohort","volume":"49","author":"Eder","year":"2010","journal-title":"Rheumatology"},{"key":"10.1111\/ced.12504-BIB0020|ced12504-cit-0020","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/acr.20162","article-title":"Frequency, predictors, and prognosis of sustained minimal disease activity in an observational psoriatic arthritis cohort","volume":"62","author":"Coates","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1111\/ced.12504-BIB0021|ced12504-cit-0021","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/00015550410001044","article-title":"The prevalence of fibromyalgia among patients with psoriasis","volume":"85","author":"Thune","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/ced.12504-BIB0022|ced12504-cit-0022","doi-asserted-by":"crossref","first-page":"762921","DOI":"10.1155\/2013\/762921","article-title":"High frequency of fibromyalgia in patients with psoriatic arthritis: a pilot study","volume":"2013","author":"Magrey","year":"2013","journal-title":"Arthritis"},{"key":"10.1111\/ced.12504-BIB0023|ced12504-cit-0023","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.3899\/jrheum.120798","article-title":"Differentiation of the clinical features of psoriatic arthritis and fibromyalgia","volume":"39","author":"Konno","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1111\/ced.12504-BIB0024|ced12504-cit-0024","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/ncprheum0880","article-title":"Adalimumab, etanercept and infliximab are equally effective treatments for patients with psoriatic arthritis","volume":"4","author":"Gladman","year":"2008","journal-title":"Nat Clin Pract Rheumatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fced.12504","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ced.12504\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:40:22Z","timestamp":1676385622000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/40\/2\/136\/6621300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,1]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"URL":"https:\/\/doi.org\/10.1111\/ced.12504","relation":{},"ISSN":["0307-6938"],"issn-type":[{"value":"0307-6938","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12,1]]}}}